• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Elbit selects restructuring adviser

Article

Israel-based Elbit has chosen Salomon Brothers of New York Cityas its financial adviser and investment banker to help plan aproposed corporate reorganization. Salomon Brothers will help Elbit managers examine the feasibilityof realigning Elbit and its

Israel-based Elbit has chosen Salomon Brothers of New York Cityas its financial adviser and investment banker to help plan aproposed corporate reorganization.

Salomon Brothers will help Elbit managers examine the feasibilityof realigning Elbit and its subsidiaries into new and independenthealthcare, defense and commercial companies. Elbit's board ofdirectors approved this examination in principle on Dec. 7 (SCAN12/27/95).

The selection of Salomon Brothers as financial adviser is oneof two interim steps toward a final reorganization plan, accordingto Dr. Thomas Spackman, president of Elscint's U.S. subsidiary.The selection of a management consultant to help guide planningis still pending, he said.

In other Elscint news, the company's shareholders have approvedthe sale of Elscint's Elscintec ultrasound subsidiary to Elbit.

Recent Videos
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
Related Content
© 2024 MJH Life Sciences

All rights reserved.